Eye Health News and Research

Latest Eye Health News and Research

St. Jude step towards cure for retinoblastoma

Investigators at St. Jude Children's Research Hospital have discovered the role of several key genes in the development of the retina, and in the process have taken a significant step toward understanding how to prevent or cure the potentially deadly eye cancer retinoblastoma.

10 May 2006

Statins may improve circulation in the eye

The cholesterol-lowering medications known as statins may improve circulation in the eye, potentially reducing the risk of certain eye diseases, according to a study in the May issue of Archives of Ophthalmology.

9 May 2006

New discovery about role of sugar in cell communication

A research team from Uppsala University has uncovered an entirely new mechanism for how communication between cells is regulated.

9 May 2006

New insight into the way an embryonic retina cell develops

The discovery provides a new vantage point for understanding how a healthy visual system develops. It also raises the possibility of re-directing the production of cell types as needed to stave off eye disease.

9 May 2006

Zoloft may prevent recurrence of depression in patients with diabetes

A team of researchers at Washington University School of Medicine in St. Louis found that an antidepressant medication may reduce the risk of recurrent depression and increase the length of time between depressive episodes in patients with diabetes.

9 May 2006

MicroCT-based virtual histology

Utah and Texas researchers combined miniature medical CT scans with high-tech computer methods to produce detailed three-dimensional images of mouse embryos - an efficient new method to test the safety of medicines and learn how mutant genes cause birth defects or cancer.

8 May 2006

Mutated gene leads to JSRD

The research team, directed by Joseph Gleeson, M.D., Director of the Neurogenetics Laboratory at the UCSD School of Medicine and associate professor in the Department of Neurosciences, have identified a new gene that, when mutated, leads to JSRD. Their findings will be published on-line in advance of publication in the journal Nature Genetics.

8 May 2006

Bladeless LASIK as good as standard microkeratome LASIK

A Mayo Clinic study comparing femtosecond (bladeless) and mechanical microkeratome LASIK surgeries has found equal results from both types six months post-surgery, using a variety of vision and eye health measurements.

3 May 2006

Obtaining and documenting informed patient consent prior to surgery

Obtaining and documenting informed patient consent prior to surgery is of vital importance, but both the process and documentation of consent can be inadequate.

3 May 2006

Compensation by tumor suppressor genes during retinal development in mice and humans

Humans are more susceptible to developing the eye cancer retinoblastoma than mice because, unlike humans, mice can compensate for the loss of activity of a gene critical to normal retinal development, according to results of a study by investigators at St. Jude Children's Research Hospital.

3 May 2006

The 30-year natural history of type 1 diabetes complications

...while cases of premature death and a few other complications have declined, rates of other serious diabetes-related disorders such as heart and eye disease have not improved over the past 25 to 30 years.

3 May 2006

New theory on how the brain detects motion

Researchers at the Salk Institute for Biological Studies have discovered a neural circuit that is likely to play an important role in the visual perception of moving objects. Their finding, published in the April issue of the journal Neuron, forces neurobiologists to rethink the neural pathways that our brain relies on to detect motion.

28 Apr 2006

Prenatal exposure to alcohol can change child's circadian rhythms

Altered sleeping and eating patterns, behavioral problems, attention deficits and depression in children with fetal alcohol spectrum disorders may indicate that their biological rhythms, which are controlled by circadian systems, have been affected by alcohol exposure during development.

25 Apr 2006

New method allows heart beat triggers to be viewed and better understood

Researchers have developed unique chemical dyes that have made it possible to see what the naked eye has never seen before: action potentials, or voltage changes, of cardiac cells - including those deep inside the heart, which trigger and determine the pace of heartbeats.

25 Apr 2006

Patching for corneal abrasion

Simple corneal abrasions do not need to be treated by patching the eye, according to a new review of studies that found patching initially slows healing and does not reduce pain.

18 Apr 2006

$Photorefractive keratectomy (PRK) versus laser-assisted in-situ keratomileusis (LASIK) for myopia$

Photorefractive keratectomy (PRK) versus laser-assisted in-situ keratomileusis (LASIK) for myopia

A new review of recent studies suggests two popular laser-assisted surgeries to correct nearsightedness are equally effective at restoring 20/20 vision six months to a year after the surgery.

18 Apr 2006

One melanoma means there's a 15% risk of another

According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.

18 Apr 2006

Johns Hopkins researchers discover gene that reduces retinal degeneration in fruit flies

Johns Hopkins researchers have discovered a gene in fruit flies that helps certain specialized neurons respond more quickly to bright light.

18 Apr 2006

Chinese surgeons carry out world's second face transplant

According to the Chinese state media a 30-year-old man has been given the country's first face transplant by Chinese doctors, the second operation of its kind in the world.

17 Apr 2006

First gene therapy human trial in the United States for a form of muscular dystrophy under way

The clinical trial for Duchenne muscular dystrophy (DMD) tests the safety and effectiveness of a therapy that was developed over two decades by scientists at the University of North Carolina Chapel Hill's School of Medicine and the University of Pittsburgh.

16 Apr 2006